Homocysteine: cardiovascular risk factor in children and adolescents?

Adriana Amorim De Farias Leal1, Astrid Camêlo Palmeira, Gabriella Menezes Almeida De Castro

  • 1Post-graduation Program in Public Health, Universidade Estadual da Paraíba, Campina Grande, PB, Brazil.

Revista Da Associacao Medica Brasileira (1992)
|November 5, 2013
PubMed

Insights

Homocysteine (He) is linked to cardiovascular diseases (CVD) in children and adolescents. Higher He levels correlate with older age and male gender, and lower vitamin levels, suggesting further research into pediatric hyperhomocysteinemia causes.

Area of Science:

  • Pediatrics
  • Cardiology
  • Biochemistry

Background:

  • Cardiovascular diseases (CVD) pose a significant health concern in pediatric populations.
  • Understanding risk factors for CVD in children and adolescents is crucial for early intervention.
  • Homocysteine (He) is a potential biomarker implicated in cardiovascular risk.

Purpose of the Study:

  • To systematically review and identify literature investigating Homocysteine (He) as a risk factor for cardiovascular diseases (CVD) in pediatric populations (children and adolescents).
  • To synthesize findings on the relationship between He levels and demographic or biochemical factors in this age group.

Main Methods:

  • A comprehensive literature search was performed across multiple databases: LILACS, IBECS, Science Direct, Medline, and Cochrane Library.
  • Keywords used included "homocysteine", "cardiovascular diseases", "child", and "adolescent".
  • Fifteen relevant articles were selected and analyzed for their findings.

Main Results:

  • A direct relationship was observed between higher Homocysteine (He) levels and increasing age (reported in 8 studies).
  • Male gender was associated with higher He levels (reported in 10 studies).
  • An inverse relationship was found between He levels and serum concentrations of vitamins B6, B12, and folate.

Conclusions:

  • The findings suggest Homocysteine (He) may be a relevant factor in pediatric cardiovascular risk.
  • Further research is warranted to elucidate the causes of hyperhomocysteinemia in the pediatric population.
  • Dietary interventions focusing on nutrients essential for He metabolism may be beneficial.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
760
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747